#USA #Berkeley Heights #Axtria #Clinical Data #LUCCID

Axtria Unveils LUCCID: A Transformative Tool for Clinical Data Management

In the rapidly evolving field of life sciences, Axtria Inc. has just made a significant leap forward with the introduction of LUCCID, short for LLM-based Unstructured Clinical Concept Identification. This state-of-the-art solution, powered by advanced Generative AI, aims to revolutionize clinical data management by dramatically enhancing the process of extracting and organizing unstructured data from electronic health records (EHR).

Understanding LUCCID's Impact

According to Luke Dunlap, who serves as Principal and Head of Clinical Solutions at Axtria, LUCCID is designed to identify clinical concepts from unstructured data sources and convert them into structured data suited for downstream clinical trial systems. A staggering portion of clinical trial budgets—nearly 30%—is typically allocated to data abstraction and validation. LUCCID has the potential to drastically reduce the time, effort, and costs traditionally associated with these processes.

The importance of automation in this sector cannot be overstated, especially with the fact that 80% of clinical trial data originates from unstructured formats. Traditional methods have proven to be slow and often error-prone, creating bottlenecks that can hinder critical research timelines. LUCCID tackles this challenge head-on, transforming the manual extraction process into a streamlined, automated workflow that promises both speed and accuracy.

The Technology Behind LUCCID

LUCCID leverages clinically trained large language models, each equipped with specialized reasoning capabilities based on robust biomedical knowledge. By utilizing these advanced models, LUCCID not only speeds up the data extraction process but also enhances the precision of data needed for successful clinical trials.

Notably, Axtria has plans to present their findings and innovations related to LUCCID at upcoming conferences such as ISPOR and SCDM later this year, highlighting their commitment to advancing the medical research collective knowledge base.

Acknowledging Axtria's Legacy

Axtria's role in the life sciences industry is noteworthy. The company currently partners with 16 of the top 20 global life sciences firms, embodying a trusted consultant and leading provider of cloud-based pharmaceutical management software. With decades of industry experience, Axtria guides pharmaceutical companies through various phases, from brand launches to product retirements.

Their comprehensive suite of products, including Axtria InsightsMAx.ai and Axtria MarketingIQ™, showcases their versatility in addressing diverse challenges within the pharmaceutical landscape. Not only do they offer solutions for optimizing field forces and omnichannel engagement, but they also provide extensive data management options tailored for emerging pharmaceutical needs.

Axtria's Commitment to Patient Outcomes

At its core, Axtria focuses on enhancing patient outcomes through data-driven insights that effectively match the right therapies to the right patients at the right time. They stand as a global leader in providing award-winning cloud software and data analytics tailored specifically to the life sciences sector. Their commitment extends beyond mere business metrics; as participants in the United Nations Global Compact, Axtria actively works on aligning its corporate strategies with key universal principles concerning human rights, labor, environmental practices, and anti-corruption efforts.

For those interested in learning more about this revolutionary tool, detailed information is available at Axtria’s website. LUCCID promises to be a game changer in the clinical trial landscape, ensuring that researchers spend less time on data management and more time progressing in their pivotal studies.